OssulinTM, a Novel Oral Insulin Product, Shows Promising Bioavailability for Advancing Diabetes Therapy
|
| Posted
:
Mon, 09 Nov 2009 10:00:37 GMT |
| Author
:
CM&D Pharma Limited
|
| Category
:
Press Release |
| News Alerts by
Email ( click
here ) |
|
|
|
|
LONDON - (Business Wire) New data from Puredel Limited, presented at the 9th Annual Diabetes Technology Meeting in San Francisco, CA, suggests that higher blood levels of insulin were achieved by Ossulin™ than had been previously demonstrated by other oral products. In a series of experiments covering a range of doses and models, Ossulin™ consistently delivered around 20% of the insulin dose into the bloodstream. The authors concluded that: | "Ossulin provides an efficient way to deliver insulin to the body via oral administration, resulting in blood levels higher than those previously observed with other oral insulin products." | Lead author and Chief Scientific Officer for Puredel, Dr. Marco Prosdocimi added: | "Oral insulin could represent a major advance in diabetes therapy through its simplicity of use, and because it mimics the natural physiological route of the hormone. The incorporation of insulin into the proprietary delivery agent NatsomTM gives rise to a product which is not destroyed by the gastric environment." | About Puredel Limited Puredel is focusing its research on the development of Ossulin™, which has shown promising results in preliminary studies. Puredel will also explore other target molecules which are currently injected, and whose oral administration would greatly improve patient convenience and compliance. Natreon’s R&D staff and facilities in the United States and India are working closely with Puredel to help facilitate the next stage of scientific validation prior to commercial development. Puredel will coordinate the product development of Ossulin™ up to proof of clinical efficacy, drawing on its extensive network of scientific experts in Europe and North America.
CM&D Pharma Limited
Stephen Appelbee, CEO, +44 20 7259 8488
appelbee@cmdpharmaltd.com
www.cmdpharmaltd.com
|
Copyright © 2008
Business Wire. All rights reserved.
|
|
|
|
|
Related
News
Dex Hamilton Goes Global with New Movie
TORONTO, Nov. 26 /PRNewswire/ - March Entertainment announced today the coming release of a full-length movie prequel to its animated adventure series Dex Hamilton: Alien Entomologist.
The movie, entitled Dex Hamilton: Fire and Ice, and the TV series w...
Greenlight Search study reveals SkyScanner and EBookers top Google search results for Q3 2009
LONDON -
Greenlight, the UK’s leading independent search marketing agency, has
released its latest integrated quarterly research for the flight
industry. The most recent study covers Q3 2009 and consists of paid
search as well as natural search analysis, to offer a fully integrated
Media Advisory: SDTC and the Government of Canada to Announce Funding for Innovative Automated Water Monitoring System
KINGSTON, ONTARIO -- 11/26/09 --
Officials from the Government of Canada and Sustainable Development Technology Canada (SDTC) will announce funding for a project led by Pathogen Detection Systems Inc. to develop and demonstrate a portable and autom..
Research and Markets: It's a Mad Mad Mad Mad 4G World
DUBLIN -
Research and Markets (
Retail Mood Lifts at MAPIC 2009
PARIS -
International retailers polled before and during MAPIC 2009, report that
they believe the market has bottomed out and that 2010 will see a
significant recovery in certain retail sectors and territories.
According to independent research carried out prior to MAPIC by C
Asian Mineral Resources Announces Proposed Private Placement and Board Appointment
TORONTO, ONTARIO -- 11/26/09 --
Asian Mineral Resources Limited (the "Company")(TSX VENTURE: ASN) announced today its intention to complete a non-brokered private placement of up to 59 million units, with each unit consisting of one common share an..
Research and Markets: Cultural Differences and Improving Performance is a Ground Breaking Book Relating to the Concept of Cultural Dimensions
DUBLIN -
Research and Markets(
|
|
|
|
|
|
|
|
|
